Development

Latest News

October 1st 2003

Validation of Commercial-Off-the-Shelf Calibration Management Systems: Managing Instruments Cost-Effectively

Biotech companies are among the most intensive instrumentation users of any FDA-regulated business. Because of the complex nature of these companies' research and manufacturing, they typically have a larger number of instruments per employee.

August 1st 2003

Large-Scale Manufacturing of Plasmid DNA for Gene Therapy and DNA Vaccination -- Part 1: The Suitability of Current Techniques to Purify Plasmid Without Adding RNase

By Alex Eon-Duval

Research into Cold Cancers Heating Up

Accurately targeted immunotherapies through reliable neoantigen recognition enable personalized medicine development.

Proprietary Cell-Line Development for High-Titer AAV Manufacturing

Proprietary cell lines offer opportunities for achieving high AAV titers.

Bracing for a Future Wave of Advanced Therapies

In the ATMP space, CGTs are hitting their stride with unprecedented approvals in the past year alone.